ACRO Leadership

The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.

All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.

Board of Directors

Jackie Kent

Executive Industry Advisor, Medidata Solutions

Paul Kirchgraber

ACRO Chair & CEO, Labcorp Drug Development

Steve Cutler


Michael Brooks

Chief Development Officer & Global Head Clinical Development Solutions, Syneos Health

Cynthia Verst

President, R&DS Design & Delivery Innovation, IQVIA

Lisa Moneymaker

Chief Technology & Product Officer, Saama Technologies

Henry McNamara

ACRO Vice-Chair & SVP & GM, Oracle Health Sciences

Scott Connor

Chief Marketing Officer, Signant Health

Peyton Howell

Chief Operating & Growth Officer, Parexel

Catherine Gregor

Chief Clinical Trial Officer, Florence Healthcare

Karen Kaucic

Chief Medical Officer, PPD Clinical Research, Thermo Fisher Scientific

Chris Fikry

President & CEO, Clario

Jim Reilly

Vice President, R&D Strategy, Veeva Systems

Become and ACRO Member and add your voice.

ACRO Staff

Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.

Doug Peddicord

Executive Director

Karen Noonan

Senior Vice President, Global Regulatory Policy

Anina Adelfio

Chief Operating Officer

Sophia McLeod

Director of Government Relations

Aislinn Quinn

Membership and Communications Coordinator